I posted a couple of times in July about this consultant after I bought back in before Q2. I was thinking Jason would start supporting the NASDAQ narrative but of course he didn't. I was able to sell for a nice flip of $1 a share before bailing right after Q2 and no conference call. He had a conference call Q2 filing 2020 and if he ever owed shareholders one it was this year.
Bubae Member Level Sunday, 07/18/21 09:26:08 AM Re: None 0 Post # 111496 of 111818 Jason has a lot of work to do to convince shareholders that they should continue to risk their money supporting what has become commonly known as a share selling scheme and burned so many so recently. I say this in full disclosure that I have taken a position in this for the first time in about a year. If Jason isn't able to support the $4.00 price level then the plan of the last year and the narrative falls apart and this once again becomes a penny stock. I’m thinking that they did not expect the price to drop so quickly and to this level after the reverse split. This should not only make them anxious to get the price stabilized but also put Jason’s dilution cravings in check.
I do want to point out that Jason did seek help last Summer. The Maxim agreement is dated August 28th which helps with uplist and other financial efforts for one. Also, the name that hasn’t been heard for a long time is Omkhar Arasaratnam. He has a one year consulting agreement which expires this month. It appears that what has happened this past year has been structured toward the stated goal with the debt clean-up and reverse split. I would expect that Omkhar Arasaratnam had some input concerning the last group of acquisitions. Jason needs actual board members other than himself so I am wondering if this person is a prospect given the serious need for credibility here. I see two payments with shares in early February to consultants in the annual 10K which could have easily converted for over $40K each at that time.
“Effective July 28, 2020, the company entered into an Advisory Board Agreement (the “Advisory Agreement”) with Omkharan Arasaratnam (the “Advisor”). Pursuant to the Advisory Agreement, the Advisor joined the Advisory Board of the Company for a term of 12-months, although either party may terminate the Advisory Agreement early upon proper notice. The Company agreed to issue to the Advisor five million (5,000,000) shares of its common stock to the Advisor, which shares shall vest at the rate of 25% every 3-months under the Advisory Agreement. The issuance was exempt under Section 4(a)(2) of the Securities Act.”
Second post about Omkharan Arasaratnam. There were a couple of payments to advisory board members in February. In shares of course. I'm sure you remember the big deal that was made about this guy summer of 2020 only to never hear is name again.
Board members for sure with people who can bring credibility to the story. I posted a couple of days ago about Omkharan Arasaratnam. I'm sure you remember that this name caused some buzz last summer when it was released. This person would be a strong candidate and already has a relationship with the company. There are two payments listed for February 3rd to consultants so it appears that he likely is still be on board. Those payments should have converted for $40K plus easily at that time.
Maxim will also profit nicely from an uplist. There is a lot of potential catalysts coming if the NASDAQ narrative is real. One would be announcing a different corporate governance structure to replace Jason's controlling interest. I have my doubts given the history.
"On February 03, 2021, the Company issued 1,250,000 shares of its common stock to a member of the Company’s Advisory Board. The issuance was exempt under Section 4(a)(2) of the Securities Act."
"On February 03, 2021, the Company issued 1,250,000 shares of its common stock to a member of the Company’s Advisory Board. The issuance was exempt under Section 4(a)(2) of the Securities Act."
“Effective July 28, 2020, the company entered into an Advisory Board Agreement (the “Advisory Agreement”) with Omkharan Arasaratnam (the “Advisor”). Pursuant to the Advisory Agreement, the Advisor joined the Advisory Board of the Company for a term of 12-months, although either party may terminate the Advisory Agreement early upon proper notice. The Company agreed to issue to the Advisor five million (5,000,000) shares of its common stock to the Advisor, which shares shall vest at the rate of 25% every 3-months under the Advisory Agreement. The issuance was exempt under Section 4(a)(2) of the Securities Act.”
Market Data 
Markets 
AI
